vs
Side-by-side financial comparison of SAUL CENTERS, INC. (BFS) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $75.1M, roughly 1.1× SAUL CENTERS, INC.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 8.7%, a 14.1% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 10.6%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 6.2%).
Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
BFS vs FDMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $85.1M |
| Net Profit | $6.5M | $19.4M |
| Gross Margin | — | — |
| Operating Margin | 65.4% | 17.3% |
| Net Margin | 8.7% | 22.8% |
| Revenue YoY | 10.6% | 8508900.0% |
| Net Profit YoY | -19.6% | 139.1% |
| EPS (diluted) | $0.15 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $85.1M | ||
| Q3 25 | $72.0M | $90.0K | ||
| Q2 25 | $70.8M | $15.0K | ||
| Q1 25 | $71.9M | $14.0K | ||
| Q4 24 | $67.9M | $1.0K | ||
| Q3 24 | $67.3M | $3.0K | ||
| Q2 24 | $66.9M | $5.0K | ||
| Q1 24 | $66.7M | $28.0K |
| Q4 25 | $6.5M | $19.4M | ||
| Q3 25 | $10.5M | $-56.9M | ||
| Q2 25 | $10.7M | $-54.7M | ||
| Q1 25 | $9.8M | $-48.0M | ||
| Q4 24 | $8.1M | — | ||
| Q3 24 | $14.5M | $-43.8M | ||
| Q2 24 | $14.4M | $-35.0M | ||
| Q1 24 | $13.6M | $-32.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 73.6% | — | ||
| Q2 24 | 74.2% | — | ||
| Q1 24 | 72.8% | — |
| Q4 25 | 65.4% | 17.3% | ||
| Q3 25 | 69.1% | -67983.3% | ||
| Q2 25 | 68.7% | -396373.3% | ||
| Q1 25 | 66.5% | -383007.1% | ||
| Q4 24 | 82.9% | — | ||
| Q3 24 | 72.8% | -1704400.0% | ||
| Q2 24 | 75.0% | -849120.0% | ||
| Q1 24 | 72.4% | -136200.0% |
| Q4 25 | 8.7% | 22.8% | ||
| Q3 25 | 14.6% | -63195.6% | ||
| Q2 25 | 15.1% | -364386.7% | ||
| Q1 25 | 13.6% | -342657.1% | ||
| Q4 24 | 11.9% | — | ||
| Q3 24 | 21.5% | -1461433.3% | ||
| Q2 24 | 21.6% | -699060.0% | ||
| Q1 24 | 20.4% | -115717.9% |
| Q4 25 | $0.15 | $0.43 | ||
| Q3 25 | $0.32 | $-1.01 | ||
| Q2 25 | $0.33 | $-0.98 | ||
| Q1 25 | $0.29 | $-0.86 | ||
| Q4 24 | $0.22 | — | ||
| Q3 24 | $0.48 | $-0.79 | ||
| Q2 24 | $0.48 | $-0.63 | ||
| Q1 24 | $0.45 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.7M | $402.7M |
| Total DebtLower is stronger | $468.4M | — |
| Stockholders' EquityBook value | $307.8M | $505.7M |
| Total Assets | $2.2B | $566.7M |
| Debt / EquityLower = less leverage | 1.52× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.7M | $402.7M | ||
| Q3 25 | $11.8M | $305.1M | ||
| Q2 25 | $5.3M | $293.2M | ||
| Q1 25 | $6.5M | $321.4M | ||
| Q4 24 | $10.3M | $424.9M | ||
| Q3 24 | $7.2M | $501.9M | ||
| Q2 24 | $6.9M | $541.9M | ||
| Q1 24 | $7.1M | $525.9M |
| Q4 25 | $468.4M | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $455.8M | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $307.8M | $505.7M | ||
| Q3 25 | $316.6M | $369.0M | ||
| Q2 25 | $322.4M | $420.9M | ||
| Q1 25 | $328.4M | $469.7M | ||
| Q4 24 | $335.8M | $510.6M | ||
| Q3 24 | $341.8M | $552.9M | ||
| Q2 24 | $345.7M | $588.3M | ||
| Q1 24 | $347.1M | $600.6M |
| Q4 25 | $2.2B | $566.7M | ||
| Q3 25 | $2.2B | $424.0M | ||
| Q2 25 | $2.1B | $473.6M | ||
| Q1 25 | $2.1B | $515.7M | ||
| Q4 24 | $2.1B | $560.4M | ||
| Q3 24 | $2.1B | $604.0M | ||
| Q2 24 | $2.1B | $620.1M | ||
| Q1 24 | $2.0B | $629.9M |
| Q4 25 | 1.52× | — | ||
| Q3 25 | 5.02× | — | ||
| Q2 25 | 4.85× | — | ||
| Q1 25 | 4.70× | — | ||
| Q4 24 | 1.36× | — | ||
| Q3 24 | 4.37× | — | ||
| Q2 24 | 4.17× | — | ||
| Q1 24 | 4.06× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $99.8M | $28.6M |
| Free Cash FlowOCF − Capex | — | $28.5M |
| FCF MarginFCF / Revenue | — | 33.5% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | 15.35× | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $99.8M | $28.6M | ||
| Q3 25 | $20.6M | $-46.5M | ||
| Q2 25 | $26.6M | $-43.4M | ||
| Q1 25 | $30.4M | $-47.8M | ||
| Q4 24 | $121.2M | $-134.6M | ||
| Q3 24 | $26.5M | $-29.4M | ||
| Q2 24 | $32.1M | $-30.2M | ||
| Q1 24 | $33.8M | $-29.1M |
| Q4 25 | — | $28.5M | ||
| Q3 25 | — | $-46.6M | ||
| Q2 25 | — | $-43.4M | ||
| Q1 25 | — | $-48.4M | ||
| Q4 24 | — | $-138.4M | ||
| Q3 24 | $-28.3M | $-31.2M | ||
| Q2 24 | $-12.5M | $-30.6M | ||
| Q1 24 | $-11.7M | $-29.8M |
| Q4 25 | — | 33.5% | ||
| Q3 25 | — | -51765.6% | ||
| Q2 25 | — | -289620.0% | ||
| Q1 25 | — | -345635.7% | ||
| Q4 24 | — | -13837100.0% | ||
| Q3 24 | -42.1% | -1038966.7% | ||
| Q2 24 | -18.7% | -611840.0% | ||
| Q1 24 | -17.6% | -106421.4% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 101.1% | ||
| Q2 25 | — | 440.0% | ||
| Q1 25 | — | 4507.1% | ||
| Q4 24 | — | 378600.0% | ||
| Q3 24 | 81.5% | 59266.7% | ||
| Q2 24 | 66.7% | 6980.0% | ||
| Q1 24 | 68.3% | 2535.7% |
| Q4 25 | 15.35× | 1.47× | ||
| Q3 25 | 1.97× | — | ||
| Q2 25 | 2.48× | — | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | 14.98× | — | ||
| Q3 24 | 1.83× | — | ||
| Q2 24 | 2.22× | — | ||
| Q1 24 | 2.48× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
